Leriglitazone (MIN-102, Hydroxypioglitazone) is an orally active and a BBB-penetrable PPARgamma agonist with an EC50 of 9 µM. Leriglitazone, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2][3][4].
Molecular Weight:
372.44
Purity:
99.23
CAS Number:
[146062-44-4]
Formula:
C19H20N2O4S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted